On this page of StockholderLetter.com we present the 4/27/2023 shareholder letter from MANNATECH INC — ticker symbol MTEX. Reading current and past MTEX letters to shareholders can bring important insights into the investment thesis.
2022 ANNUAL REPORT
TO OUR SHAREHOLDERS Throughout 2022, Mannatech continued to establish itself as a premier, global health and wellness lifestyle company, whose mission is to help others feel better, look better and live better. Despite challenges to our global operations, including supply chain issues, FDA interference, FTC warnings of rule making and additional tax assessments, Mannatech continued to show resilience by building a strong foundation for the years ahead. Our focus on innovation and product development continued, and in 2022, Mannatech introduced several existing products into new markets, including Superfood Greens and Reds in the United States, the Luminovation skincare line in Hong Kong and Japan, and our flagship products Manapol and Ambrotose LIFE in Canada. In addition, two unique drink mixes launched in Mexico, MannaForce+ and M Gold+. These products have received positive feedback from our Associates and Customers, and we believe they will continue to drive growth in the coming years. Our M5M Foundation continued to adapt well to the changing world conditions. More than thirteen million servings of PhytoBlend nutritional supplement were donated in 2022 to children in need in 21 countries. Additionally, with help from the faith-based Kids Around the World organization, the foundation helped pack and serve meals to communities in Ecuador, Dominican Republic, Ukraine, Costa Rica and Uganda. In addition, volunteers from Mannatech helped build three playgrounds in Ecuador, including the monumental KATW Playground 1000. As we look to 2023, we will remain focused on supporting the efforts of our 145,000 active Associates and Preferred Customers in 25 markets. We plan to introduce revolutionary new products, pursue global growth opportunities, and continue our investment in digital commerce. We will continue to focus on elevating the Customer and Associate Experience as we strive to help everyone live their very best lives. As always, we will continue to strive to create an environment committed to increasing shareholder value through quarterly dividends and buying back stock when appropriate. We appreciate your continued support of Mannatech! J. Stanley Fredrick Chairman of the Board Alfredo Bala CEO and President Financial Condition 2021 2022 Total cash $24 $14 Total working capital $13 $5 For the year ended in December 31 (in millions, except per share information and ratios) 2021 2022 Net sales $160 $137 Gross profit $126 $104 Income (loss) before income taxes $8.9 ($0.5) Total assets $60 $49 Income (loss) $9.8 ($4.5) Total shareholders equity $24 $14 Cash flows from operations $11 ($3) 2021 2022 Current ratio 1.4 1.2 Inventory turnover ratio 2.7 2.5 Results of Operations 2021 2022 Basic $4.95 ($2.4) Diluted $4.71 ($2.4) Earnings (loss) per Share Weighted-average shares outstanding (in thousands) Statistics Basic 1,990 1,913 Debt-to-equity ratio 1.40 2.47 Diluted 2,088 1,913 Dividends paid per share $2.22 $0.80
 • shareholder letter icon 4/27/2023 Letter Continued (Full PDF)
 • stockholder letter icon 4/22/2024 MTEX Stockholder Letter
 • stockholder letter icon 4/22/2025 MTEX Stockholder Letter
 • stockholder letter icon More "Consumer Goods" Category Stockholder Letters
 • Benford's Law Stocks icon MTEX Benford's Law Stock Score = 75


MTEX 4/27/2023 Shareholder/Stockholder Letter Transcript:

2022 ANNUAL REPORT

TO OUR SHAREHOLDERS
Throughout 2022, Mannatech continued to establish
itself as a premier, global health and wellness lifestyle
company, whose mission is to help others feel better,
look better and live better. Despite challenges to
our global operations, including supply chain issues,
FDA interference, FTC warnings of rule making and
additional tax assessments, Mannatech continued to
show resilience by building a strong foundation for the
years ahead.
Our focus on innovation and product development
continued, and in 2022, Mannatech introduced several
existing products into new markets, including
Superfood Greens and Reds in the United States, the
Luminovation   skincare line in Hong Kong and Japan,
and our flagship products Manapol   and Ambrotose
LIFE   in Canada. In addition, two unique drink mixes
launched in Mexico, MannaForce+ and M Gold+. These
products have received positive feedback from our
Associates and Customers, and we believe they will
continue to drive growth in the coming years.
Our M5M Foundation continued to adapt well to the
changing world conditions. More than thirteen million
servings of PhytoBlend    nutritional supplement were
donated in 2022 to children in need in 21 countries.
Additionally, with help from the faith-based Kids Around
the World organization, the foundation helped pack
and serve meals to communities in Ecuador, Dominican
Republic, Ukraine, Costa Rica and Uganda. In addition,
volunteers from Mannatech helped build three
playgrounds in Ecuador, including the monumental
KATW Playground 1000.
As we look to 2023, we will remain focused on
supporting the efforts of our 145,000 active Associates
and Preferred Customers in 25 markets. We plan to
introduce revolutionary new products, pursue global
growth opportunities, and continue our investment in
digital commerce. We will continue to focus on elevating
the Customer and Associate Experience as we strive to
help everyone live their very best lives.
As always, we will continue to strive to create an
environment committed to increasing shareholder value
through quarterly dividends and buying back stock
when appropriate.
We appreciate your continued support of Mannatech!
J. Stanley Fredrick
Chairman of the Board
Alfredo Bala
CEO and President
Financial Condition
2021
2022
Total cash
$24
$14
Total working capital
$13
$5
For the year ended in December 31
(in millions, except per share information and ratios)
2021
2022
Net sales
$160
$137
Gross profit
$126
$104
Income (loss) before
income taxes
$8.9
($0.5)
Total assets
$60
$49
Income (loss)
$9.8
($4.5)
Total shareholders    equity
$24
$14
Cash flows from operations
$11
($3)
2021
2022
Current ratio
1.4
1.2
Inventory turnover ratio
2.7
2.5
Results of Operations
2021
2022
Basic
$4.95
($2.4)
Diluted
$4.71
($2.4)
Earnings (loss) per Share
Weighted-average shares
outstanding (in thousands)
Statistics
Basic
1,990
1,913
Debt-to-equity ratio
1.40
2.47
Diluted
2,088
1,913
Dividends paid per share
$2.22
$0.80


shareholder letter icon 4/27/2023 Letter Continued (Full PDF)
 

MTEX Stockholder/Shareholder Letter (MANNATECH INC) 4/27/2023 | www.StockholderLetter.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.